The utility of PAX8 and SATB2 immunohistochemical stains in distinguishing ovarian mucinous neoplasms from colonic and appendiceal mucinous neoplasm

[1] Lee KR(2003)The distinction between primary and metastatic mucinous carcinomas of the ovary: gross and histologic findings in 50 cases Am J Surg Pathol 27 281-292

[2] Young RH(1997)The morphologic spectrum of ovarian metastases of appendiceal adenocarcinomas: a clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other gastrointestinal sites Am J Surg Pathol 21 1144-1155

[3] Ronnett BM(1992)Metastatic ovarian carcinoma of large intestinal origin simulating primary ovarian carcinoma: a clinicopathologic study of 25 cases Am J Clin Pathol 97 751-758

[4] Kurman RJ(2006)Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases Am J Surg Pathol 30 1130-1139

[5] Shmookler BM(2010)CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma Jpn J Clin Oncol 40 208-213

[6] Sugarbaker PH(2010)Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases Int J Gynecol Pathol 29 99-107

[7] Young RH(2006)Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7 Mod Pathol 19 1421-1428

[8] Daya D(2011)PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study Mod Pathol 24 751-764

[9] Nazerali L(2011)A comprehensive analysis of PAX8 expression in human epithelial tumors Am J Surg Pathol 35 816-826

[10] Frank GL(2013)PAX8 mouse monoclonal antibody [BC12] recognizes a restricted epitope and is highly sensitive in renal cell and ovarian cancers but does not cross-react with b cells and tumors of pancreatic origin Appl Immunohistochem Mol Morphol 21 59-63

[1] Lee KR(2003)The distinction between primary and metastatic mucinous carcinomas of the ovary: gross and histologic findings in 50 cases Am J Surg Pathol 27 281-292

[2] Young RH(1997)The morphologic spectrum of ovarian metastases of appendiceal adenocarcinomas: a clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other gastrointestinal sites Am J Surg Pathol 21 1144-1155

[3] Ronnett BM(1992)Metastatic ovarian carcinoma of large intestinal origin simulating primary ovarian carcinoma: a clinicopathologic study of 25 cases Am J Clin Pathol 97 751-758

[4] Kurman RJ(2006)Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases Am J Surg Pathol 30 1130-1139

[5] Shmookler BM(2010)CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma Jpn J Clin Oncol 40 208-213

[6] Sugarbaker PH(2010)Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases Int J Gynecol Pathol 29 99-107

[7] Young RH(2006)Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7 Mod Pathol 19 1421-1428

[8] Daya D(2011)PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study Mod Pathol 24 751-764

[9] Nazerali L(2011)A comprehensive analysis of PAX8 expression in human epithelial tumors Am J Surg Pathol 35 816-826

[10] Frank GL(2013)PAX8 mouse monoclonal antibody [BC12] recognizes a restricted epitope and is highly sensitive in renal cell and ovarian cancers but does not cross-react with b cells and tumors of pancreatic origin Appl Immunohistochem Mol Morphol 21 59-63